Effect of Aerobic Training and Moringa Oleifera on Dyslipidemia and Cardiac Endurance
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04164771 |
Recruitment Status :
Not yet recruiting
First Posted : November 15, 2019
Last Update Posted : December 18, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Dyslipidemias | Other: Aerobic training and Moringa Oleifera | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 120 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Health Services Research |
Official Title: | Effect of Aerobic Training and Moringa Oleifera on Dyslipidemia and Cardiac Endurance |
Estimated Study Start Date : | February 2020 |
Estimated Primary Completion Date : | April 2020 |
Estimated Study Completion Date : | July 2020 |
Arm | Intervention/treatment |
---|---|
Experimental: Moringa Group
Participants will receive 5-7g of moringa diet daily for 6 weeks.
|
Other: Aerobic training and Moringa Oleifera
Aerobic exercises/training refers to any type of rhythmic, continuous physical activities that use large group of muscles like walking, running, cycling, and swimming consuming additional amount of energy while Moringa Oleifera a plant from the family Moringacea, its products are used as a health supplement introduced in Africa and south Asian countries to cure many diseases and improve health status |
Experimental: Aerobic training Group
Participants will receive 5-7g of moringa diet daily and will do 30 minutes of aerobic training daily for 6 weeks.
|
Other: Aerobic training and Moringa Oleifera
Aerobic exercises/training refers to any type of rhythmic, continuous physical activities that use large group of muscles like walking, running, cycling, and swimming consuming additional amount of energy while Moringa Oleifera a plant from the family Moringacea, its products are used as a health supplement introduced in Africa and south Asian countries to cure many diseases and improve health status |
Experimental: Moringa and Aerobic training
Participants will do 30 minutes of aerobic training daily for 6 weeks
|
Other: Aerobic training and Moringa Oleifera
Aerobic exercises/training refers to any type of rhythmic, continuous physical activities that use large group of muscles like walking, running, cycling, and swimming consuming additional amount of energy while Moringa Oleifera a plant from the family Moringacea, its products are used as a health supplement introduced in Africa and south Asian countries to cure many diseases and improve health status |
No Intervention: Control Group (T4)
Participants will not recieve any treatment
|
- Positive effect of aerobic training and Moringa Oleifera on dyslipidemia and cardiac endurance [ Time Frame: 6 weeks ]Change in level of HDL, LDL and triglyceride, impact on cardiac endurance

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 50 Years (Adult) |
Sexes Eligible for Study: | Male |
Gender Based Eligibility: | Yes |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy and no medical conditions.
- LDL level should be 160-189 mg/dl
- HDL level should be < 40 mg/dl
- Tri glyceride level should be 200-499 mg/dl
- Total cholesterol level should be > 200 mg/dl).
- Beep Test score should be less than 10.5 or less than 40% vo2 max
Exclusion Criteria:
- Any disease condition as anemia, physical injuries, chronic disease
- Not capable of doing aerobic training

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04164771
Contact: Naseer Ahmed, Ph.D | 03333382013 ext 4465 | dr.naseer99@gmail.com | |
Contact: Javeria Farooq, M.Phil | 03343585849 | javeria.farooq@aku.edu |
Principal Investigator: | Naseer Ahmed, Ph.D | Agha Khan Hospital |
Responsible Party: | NASEER AHMED, Assistant Professor, Aga Khan University |
ClinicalTrials.gov Identifier: | NCT04164771 |
Other Study ID Numbers: |
NA 125 |
First Posted: | November 15, 2019 Key Record Dates |
Last Update Posted: | December 18, 2019 |
Last Verified: | December 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Aerobic training Moringa Cardioprotection |
Dyslipidemias Lipid Metabolism Disorders Metabolic Diseases |